tradingkey.logo

Standard BioTools Inc

LAB
1.260USD
+0.020+1.61%
終値 02/06, 16:00ET15分遅れの株価
483.35M時価総額
損失額直近12ヶ月PER

Standard BioTools Inc

1.260
+0.020+1.61%

詳細情報 Standard BioTools Inc 企業名

Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.

Standard BioTools Incの企業情報

企業コードLAB
会社名Standard BioTools Inc
上場日Feb 10, 2011
最高経営責任者「CEO」Egholm (Michael)
従業員数818
証券種類Ordinary Share
決算期末Feb 10
本社所在地2 Tower Place
都市SOUTH SAN FRANCISCO
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号94080
電話番号16502666000
ウェブサイトhttps://www.standardbio.com/
企業コードLAB
上場日Feb 10, 2011
最高経営責任者「CEO」Egholm (Michael)

Standard BioTools Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
157.01K
+94592.00%
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
65.77K
-19661.00%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
157.01K
+94592.00%
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
65.77K
-19661.00%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Consumables
8.71M
44.52%
Services and other revenue
5.75M
29.42%
Instruments
5.09M
26.06%
地域別USD
会社名
収益
比率
Americas
7.84M
40.11%
Europe & Middle East & Africa (EMEA)
7.25M
37.06%
Asia-Pacific
4.46M
22.84%
事業別
地域別
事業別USD
会社名
収益
比率
Consumables
8.71M
44.52%
Services and other revenue
5.75M
29.42%
Instruments
5.09M
26.06%

株主

更新時刻: Sat, Nov 15
更新時刻: Sat, Nov 15
株主統計
種類
株主統計
株主統計
比率
Casdin Capital, LLC
23.09%
Viking Global Investors LP
15.25%
BlackRock Institutional Trust Company, N.A.
5.67%
MAK Capital One, LLC
5.19%
The Vanguard Group, Inc.
4.48%
他の
46.31%
株主統計
株主統計
比率
Casdin Capital, LLC
23.09%
Viking Global Investors LP
15.25%
BlackRock Institutional Trust Company, N.A.
5.67%
MAK Capital One, LLC
5.19%
The Vanguard Group, Inc.
4.48%
他の
46.31%
種類
株主統計
比率
Hedge Fund
33.44%
Investment Advisor/Hedge Fund
27.49%
Investment Advisor
14.80%
Individual Investor
2.53%
Research Firm
0.66%
Venture Capital
0.57%
Bank and Trust
0.24%
Pension Fund
0.11%
Insurance Company
0.02%
他の
20.13%

機関投資家保有株

更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
332
297.38M
77.33%
-29.00M
2025Q3
324
277.96M
72.29%
-27.47M
2025Q2
337
283.64M
74.68%
-28.24M
2025Q1
336
286.88M
75.60%
-24.96M
2024Q4
322
279.84M
75.18%
-22.14M
2024Q3
315
282.67M
78.53%
-14.93M
2024Q2
303
268.49M
74.97%
-14.97M
2024Q1
306
263.03M
71.99%
+131.65M
2023Q4
264
54.09M
66.99%
-14.10M
2023Q3
265
53.37M
67.31%
-13.39M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Casdin Capital, LLC
88.78M
23.09%
+350.00K
+0.40%
Dec 04, 2025
Viking Global Investors LP
58.65M
15.25%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
21.81M
5.67%
+20.05K
+0.09%
Sep 30, 2025
MAK Capital One, LLC
15.93M
4.14%
+10.33M
+184.63%
Sep 30, 2025
The Vanguard Group, Inc.
17.19M
4.47%
+263.85K
+1.56%
Sep 30, 2025
Long Focus Capital Management LLC
11.36M
2.95%
+1.29M
+12.84%
Sep 30, 2025
Geode Capital Management, L.L.C.
7.47M
1.94%
+27.78K
+0.37%
Sep 30, 2025
State Street Investment Management (US)
6.40M
1.66%
+101.35K
+1.61%
Sep 30, 2025
Hollow Brook Wealth Management, LLC
5.78M
1.5%
+165.43K
+2.95%
Sep 30, 2025
Morgan Stanley Investment Management Inc. (US)
5.64M
1.47%
+285.46K
+5.33%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Invesco NASDAQ Future Gen 200 ETF
0.51%
ARK Genomic Revolution ETF
0.33%
iShares Micro-Cap ETF
0.07%
iShares Biotechnology ETF
0.04%
iShares Russell 2000 Value ETF
0.03%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.02%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Fidelity MSCI Health Care Index ETF
0.01%
詳細を見る
Invesco NASDAQ Future Gen 200 ETF
比率0.51%
ARK Genomic Revolution ETF
比率0.33%
iShares Micro-Cap ETF
比率0.07%
iShares Biotechnology ETF
比率0.04%
iShares Russell 2000 Value ETF
比率0.03%
ProShares Hedge Replication ETF
比率0.02%
ProShares UltraPro Russell2000
比率0.02%
iShares Russell 2000 ETF
比率0.01%
Global X Russell 2000 ETF
比率0.01%
Fidelity MSCI Health Care Index ETF
比率0.01%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI